| News | Events |
| Publications | Companies |
| Clinical Trials |
Monthly Archives: August 2009
-
Contine Reading & Discuss→
-
Contine Reading & Discuss→Silence Therapeutics signs siRNA delivery collaboration with Dainippon Sumitomo Pharma
0 Replies
-
Contine Reading & Discuss→Holding in Company
0 Replies
-
Santaris Pharma A/S and Shire plc to engage in a multi-year research program utilizing Santaris Pharma’s proprietary Locked Nucleic Acid (LNA) Drug Platform to identify and select drug candidates against certain targets for the treatment of rare genetic disorders Santaris Pharma A/S to receive significant upfront payments, milestone payments and... Contine Reading & Discuss→Santaris Pharma A/S forms strategic alliance with Shire plc to develop RNA-based medicines for the treatment of rare genetic disorders
0 Replies

